114116 Real-world comparative data provide further context with regard to vascular safety
Patient safety advice includes: Report persistent vomiting or signs of dehydration promptly to your healthcare provider Seek urgent medical care for severe abdominal pain, especially if radiating to the back Be aware of symptoms of hypoglycaemia if taking other diabetes medications Inform your doctor if you are planning pregnancy, as GLP-1 receptor agonists should be discontinued (at least 2 months before planned pregnancy for semaglutide) [1] [7] Attend regular follow-up appointments to monitor treatment response and side effects Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)

What to track Keep a simple daily log that records bowel movement frequency (how many per day), stool consistency (use the Bristol Stool Scale, aiming for Type 3 or 4), ease of passage (straining versus comfortable), abdominal symptoms (bloating, cramping, gas), water intake (in ounces), fiber intake (approximate grams), exercise (type and duration), and any supplements or laxatives used
Meghan Garcia-Webb, MD, who is triple board certified in internal medicine, lifestyle medicine, and obesity medicine